254 related articles for article (PubMed ID: 33602926)
21. Predicting results of mycobacterial culture on sputum smear reversion after anti-tuberculous treatment: a case control study.
Shu CC; Wang JT; Lee CH; Wang JY; Lee LN; Yu CJ
BMC Infect Dis; 2010 Mar; 10():48. PubMed ID: 20205743
[TBL] [Abstract][Full Text] [Related]
22. A computational tool integrating host immunity with antibiotic dynamics to study tuberculosis treatment.
Pienaar E; Cilfone NA; Lin PL; Dartois V; Mattila JT; Butler JR; Flynn JL; Kirschner DE; Linderman JJ
J Theor Biol; 2015 Feb; 367():166-179. PubMed ID: 25497475
[TBL] [Abstract][Full Text] [Related]
23. Anaerobe-enriched gut microbiota predicts pro-inflammatory responses in pulmonary tuberculosis.
Naidoo CC; Nyawo GR; Sulaiman I; Wu BG; Turner CT; Bu K; Palmer Z; Li Y; Reeve BWP; Moodley S; Jackson JG; Limberis J; Diacon AH; van Helden PD; Clemente JC; Warren RM; Noursadeghi M; Segal LN; Theron G
EBioMedicine; 2021 May; 67():103374. PubMed ID: 33975252
[TBL] [Abstract][Full Text] [Related]
24. Nutrition, Inflammation, and the Gut Microbiota among Outpatients with Active Tuberculosis Disease in India.
Huey SL; Yu EA; Finkelstein JL; Glesby MJ; Bonam W; Russell DG; Mehta S
Am J Trop Med Hyg; 2021 Oct; 105(6):1645-1656. PubMed ID: 34662867
[TBL] [Abstract][Full Text] [Related]
25. Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response.
Warsinske HC; Rao AM; Moreira FMF; Santos PCP; Liu AB; Scott M; Malherbe ST; Ronacher K; Walzl G; Winter J; Sweeney TE; Croda J; Andrews JR; Khatri P
JAMA Netw Open; 2018 Oct; 1(6):e183779. PubMed ID: 30646264
[TBL] [Abstract][Full Text] [Related]
26. The Human Microbiome in the Fight Against Tuberculosis.
Wood MR; Yu EA; Mehta S
Am J Trop Med Hyg; 2017 Jun; 96(6):1274-1284. PubMed ID: 28719264
[TBL] [Abstract][Full Text] [Related]
27. All-trans Retinoic Acid Augments Autophagy during Intracellular Bacterial Infection.
Coleman MM; Basdeo SA; Coleman AM; Cheallaigh CN; Peral de Castro C; McLaughlin AM; Dunne PJ; Harris J; Keane J
Am J Respir Cell Mol Biol; 2018 Nov; 59(5):548-556. PubMed ID: 29852080
[TBL] [Abstract][Full Text] [Related]
28. Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis-infected macrophages.
Genestet C; Bernard-Barret F; Hodille E; Ginevra C; Ader F; Goutelle S; Lina G; Dumitrescu O;
Tuberculosis (Edinb); 2018 Jul; 111():67-70. PubMed ID: 30029917
[TBL] [Abstract][Full Text] [Related]
29. Does discovery of differentially culturable M tuberculosis really demand a new treatment paradigm? Longitudinal analysis of DNA clearance from sputum.
Walter ND; Moore CM; Kayigire XA; Dide-Agossou C; Worodria W; Huang L; Everett CK; Schoolnik GS; Nahid P; Davis JL
BMC Infect Dis; 2018 Jul; 18(1):293. PubMed ID: 29970012
[TBL] [Abstract][Full Text] [Related]
30. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
Negi S; Pahari S; Bashir H; Agrewala JN
Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
[TBL] [Abstract][Full Text] [Related]
31. Profiling the airway in the macaque model of tuberculosis reveals variable microbial dysbiosis and alteration of community structure.
Cadena AM; Ma Y; Ding T; Bryant M; Maiello P; Geber A; Lin PL; Flynn JL; Ghedin E
Microbiome; 2018 Oct; 6(1):180. PubMed ID: 30301469
[TBL] [Abstract][Full Text] [Related]
32. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
33. Expression of nuclear factor, erythroid 2-like 2-mediated genes differentiates tuberculosis.
Qian Z; Lv J; Kelly GT; Wang H; Zhang X; Gu W; Yin X; Wang T; Zhou T
Tuberculosis (Edinb); 2016 Jul; 99():56-62. PubMed ID: 27450006
[TBL] [Abstract][Full Text] [Related]
34. Genetics-directed drug discovery for combating Mycobacterium tuberculosis infection.
Quan Y; Xiong L; Chen J; Zhang HY
J Biomol Struct Dyn; 2017 Feb; 35(3):616-621. PubMed ID: 26900080
[TBL] [Abstract][Full Text] [Related]
35. The Microbiota of Human Lung of Pulmonary Tuberculosis and the Alteration Caused by Anti-tuberculosis Drugs.
Zhang M; Shen L; Zhou X; Chen H
Curr Microbiol; 2022 Sep; 79(11):321. PubMed ID: 36121489
[TBL] [Abstract][Full Text] [Related]
36. Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.
Wipperman MF; Fitzgerald DW; Juste MAJ; Taur Y; Namasivayam S; Sher A; Bean JM; Bucci V; Glickman MS
Sci Rep; 2017 Sep; 7(1):10767. PubMed ID: 28883399
[TBL] [Abstract][Full Text] [Related]
37. A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis.
Nathan C; Gold B; Lin G; Stegman M; de Carvalho LP; Vandal O; Venugopal A; Bryk R
Tuberculosis (Edinb); 2008 Aug; 88 Suppl 1():S25-33. PubMed ID: 18762150
[TBL] [Abstract][Full Text] [Related]
38. Microbiome diversity in the sputum of patients with pulmonary tuberculosis.
Krishna P; Jain A; Bisen PS
Eur J Clin Microbiol Infect Dis; 2016 Jul; 35(7):1205-10. PubMed ID: 27142586
[TBL] [Abstract][Full Text] [Related]
39. Harnessing Biological Insight to Accelerate Tuberculosis Drug Discovery.
de Wet TJ; Warner DF; Mizrahi V
Acc Chem Res; 2019 Aug; 52(8):2340-2348. PubMed ID: 31361123
[TBL] [Abstract][Full Text] [Related]
40. A Tuberculosis Molecular Bacterial Load Assay (TB-MBLA).
Sabiiti W; Mtafya B; De Lima DA; Dombay E; Baron VO; Azam K; Oravcova K; Sloan DJ; Gillespie SH
J Vis Exp; 2020 Apr; (158):. PubMed ID: 32420999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
